128 related articles for article (PubMed ID: 22255596)
21. Converting a breast cancer microarray signature into a high-throughput diagnostic test.
Glas AM; Floore A; Delahaye LJ; Witteveen AT; Pover RC; Bakx N; Lahti-Domenici JS; Bruinsma TJ; Warmoes MO; Bernards R; Wessels LF; Van't Veer LJ
BMC Genomics; 2006 Oct; 7():278. PubMed ID: 17074082
[TBL] [Abstract][Full Text] [Related]
22. Serial analysis of 38 proteins during the progression of human breast tumor in mice using an antibody colocalization microarray.
Li H; Bergeron S; Annis MG; Siegel PM; Juncker D
Mol Cell Proteomics; 2015 Apr; 14(4):1024-37. PubMed ID: 25680959
[TBL] [Abstract][Full Text] [Related]
23. Tree-based machine learning algorithms identified minimal set of miRNA biomarkers for breast cancer diagnosis and molecular subtyping.
Sherafatian M
Gene; 2018 Nov; 677():111-118. PubMed ID: 30055304
[TBL] [Abstract][Full Text] [Related]
24. Genes and functions from breast cancer signatures.
Huang S; Murphy L; Xu W
BMC Cancer; 2018 Apr; 18(1):473. PubMed ID: 29699511
[TBL] [Abstract][Full Text] [Related]
25. Tumor tissue protein signatures reflect histological grade of breast cancer.
Skoog P; Ohlsson M; Fernö M; Rydén L; Borrebaeck CAK; Wingren C
PLoS One; 2017; 12(6):e0179775. PubMed ID: 28650989
[TBL] [Abstract][Full Text] [Related]
26. A probabilistic approach for automated discovery of perturbed genes using expression data from microarray or RNA-Seq.
Sundaramurthy G; Eghbalnia HR
Comput Biol Med; 2015 Dec; 67():29-40. PubMed ID: 26492320
[TBL] [Abstract][Full Text] [Related]
27. Incorporating prior biological knowledge for network-based differential gene expression analysis using differentially weighted graphical LASSO.
Zuo Y; Cui Y; Yu G; Li R; Ressom HW
BMC Bioinformatics; 2017 Feb; 18(1):99. PubMed ID: 28187708
[TBL] [Abstract][Full Text] [Related]
28. AGR3 in breast cancer: prognostic impact and suitable serum-based biomarker for early cancer detection.
Garczyk S; von Stillfried S; Antonopoulos W; Hartmann A; Schrauder MG; Fasching PA; Anzeneder T; Tannapfel A; Ergönenc Y; Knüchel R; Rose M; Dahl E
PLoS One; 2015; 10(4):e0122106. PubMed ID: 25875093
[TBL] [Abstract][Full Text] [Related]
29. Signatures of tumor-immune interactions as biomarkers for breast cancer prognosis.
Manjili MH; Najarian K; Wang XY
Future Oncol; 2012 Jun; 8(6):703-11. PubMed ID: 22764768
[TBL] [Abstract][Full Text] [Related]
30. Some comments on instability of false discovery rate estimation.
Qiu X; Yakovlev A
J Bioinform Comput Biol; 2006 Oct; 4(5):1057-68. PubMed ID: 17099941
[TBL] [Abstract][Full Text] [Related]
31. On-treatment biomarkers can improve prediction of response to neoadjuvant chemotherapy in breast cancer.
Bownes RJ; Turnbull AK; Martinez-Perez C; Cameron DA; Sims AH; Oikonomidou O
Breast Cancer Res; 2019 Jun; 21(1):73. PubMed ID: 31200764
[TBL] [Abstract][Full Text] [Related]
32. Multiclass cancer classification and biomarker discovery using GA-based algorithms.
Liu JJ; Cutler G; Li W; Pan Z; Peng S; Hoey T; Chen L; Ling XB
Bioinformatics; 2005 Jun; 21(11):2691-7. PubMed ID: 15814557
[TBL] [Abstract][Full Text] [Related]
33. Comparison and unification of genomic signatures in breast cancer.
Blazadonakis ME; Zervakis ME
Annu Int Conf IEEE Eng Med Biol Soc; 2009; 2009():3869-72. PubMed ID: 19963602
[TBL] [Abstract][Full Text] [Related]
34. Outcome signature genes in breast cancer: is there a unique set?
Ein-Dor L; Kela I; Getz G; Givol D; Domany E
Bioinformatics; 2005 Jan; 21(2):171-8. PubMed ID: 15308542
[TBL] [Abstract][Full Text] [Related]
35. Relative Prognostic and Predictive Value of Gene Signature and Histologic Grade in Estrogen Receptor-Positive, HER2-Negative Breast Cancer.
Iwamoto T; Kelly C; Mizoo T; Nogami T; Motoki T; Shien T; Taira N; Hayashi N; Niikura N; Fujiwara T; Doihara H; Matsuoka J
Clin Breast Cancer; 2016 Apr; 16(2):95-100.e1. PubMed ID: 26631838
[TBL] [Abstract][Full Text] [Related]
36. Cancer Progression Prediction Using Gene Interaction Regularized Elastic Net.
Lin Zhang ; Hui Liu ; Yufei Huang ; Xuesong Wang ; Yidong Chen ; Jia Meng
IEEE/ACM Trans Comput Biol Bioinform; 2017; 14(1):145-154. PubMed ID: 28055897
[TBL] [Abstract][Full Text] [Related]
37. Prognostic gene expression signatures of breast cancer are lacking a sensible biological meaning.
Manjang K; Tripathi S; Yli-Harja O; Dehmer M; Glazko G; Emmert-Streib F
Sci Rep; 2021 Jan; 11(1):156. PubMed ID: 33420139
[TBL] [Abstract][Full Text] [Related]
38. Housekeeping genes in cancer: normalization of array data.
Khimani AH; Mhashilkar AM; Mikulskis A; O'Malley M; Liao J; Golenko EE; Mayer P; Chada S; Killian JB; Lott ST
Biotechniques; 2005 May; 38(5):739-45. PubMed ID: 15948292
[TBL] [Abstract][Full Text] [Related]
39. Biomolecular features of clinical relevance in breast cancer.
Daidone MG; Paradiso A; Gion M; Harbeck N; Sweep F; Schmitt M
Eur J Nucl Med Mol Imaging; 2004 Jun; 31 Suppl 1():S3-14. PubMed ID: 15095022
[TBL] [Abstract][Full Text] [Related]
40. Profiling activities of transcription factors in breast cancer cell lines.
Jiang X; Roth L; Lai C; Li X
Assay Drug Dev Technol; 2006 Jun; 4(3):293-305. PubMed ID: 16834535
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
